Sunday, May 18, 2025
spot_imgspot_img

Top 5 This Week

spot_imgspot_img

Related Posts

Sharps Technology Lands $400K Initial Purchase Order from

Sharps Technology Secures First Revenue Milestone Under $50 Million Syringe Agreement

NEW YORK, April 30, 2025 – Sharps Technology, Inc. (NASDAQ: STSS), a pioneering medical device and pharmaceutical packaging company, has achieved a significant milestone with a $400,000 purchase order from a leading U.S. manufacturer of IV flushing solutions. This order marks the first revenue generation under a previously announced five-year supply agreement worth approximately $50 million for 500 million 10mL SoloGard syringes.

CEO Robert Hayes expressed enthusiasm for the order, noting it signifies the transition from agreement to execution. "Our Hungarian manufacturing facility is poised to deliver the initial orders of these innovative syringes, allowing us to recognize our first revenue of 2025," he stated, highlighting the long-term value expected from this strategic partnership.

Sharps’ production capacity is being augmented through substantial investments in state-of-the-art manufacturing technology, including precision molding and automation partnerships with industry leaders such as Husky Medical Molds and BBS Automation. These enhancements are designed to streamline production processes and improve product quality, vital for meeting the robust demand anticipated under the agreement.

Braden Miller, Vice President of Product and Program Management, emphasized the company’s commitment to manufacturing efficiency and sustainability through these technological upgrades. “By leveraging advanced automation, we are ensuring accelerated delivery against this significant contract, while maintaining superior quality standards,” he noted.

Sharps Technology, known for its patented smart-safety syringe products, continues to innovate in the healthcare sector, addressing the needs for ultra-low waste capabilities and enhanced safety features. For more information, visit www.sharpstechnology.com.

Investor Contact:
Holdsworth Partners
Adam Holdsworth
Phone: 917-497-9287
Email: IR@sharpstechnology.com

Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles